ANI Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BST:BSFA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 May 26	Sell€962,560	Patrick Walsh	Individual	13,973	€68.96
12 May 26	Sell€31,009	Thomas Rowland	Individual	459	€67.56
12 May 26	Sell€187,957	Ori Gutwerg	Individual	2,772	€67.81
11 May 26	Sell€3,620,425	Nikhil Lalwani	Individual	55,000	€65.83
11 Mar 26	Sell€308,890	Thomas Rowland	Individual	4,772	€64.73
05 Mar 26	Sell€261,377	Stephen Carey	Individual	4,000	€65.34
03 Mar 26	Sell€384,096	Patrick Walsh	Individual	6,000	€64.02
03 Mar 26	Sell€135,906	Ori Gutwerg	Individual	2,060	€65.97
05 Dec 25	Sell€125,562	Renee Tannenbaum	Individual	1,800	€69.76
13 Nov 25	Sell€645,026	Patrick Walsh	Individual	8,643	€74.63
13 Nov 25	Sell€7,106	Chad Gassert	Individual	94	€75.59
12 Nov 25	Sell€1,124,971	Chad Gassert	Individual	14,642	€76.83
03 Sep 25	Sell€592,819	Antonio Pera	Individual	7,292	€81.30
25 Aug 25	Sell€196,076	Matthew Leonard	Individual	2,528	€77.56
22 Aug 25	Sell€136,952	Krista Davis	Individual	1,763	€77.68
21 Aug 25	Sell€7,780,906	Esjay Llc	Company	100,000	€77.88
20 Aug 25	Sell€417,159	Antonio Pera	Individual	5,421	€76.95
18 Aug 25	Sell€524,171	Matthew Leonard	Individual	6,937	€75.56
18 Aug 25	Sell€1,645,757	Jeanne Thoma	Individual	21,540	€76.92
15 Aug 25	Sell€684,438	Patrick Walsh	Individual	9,000	€76.05
15 Aug 25	Sell€1,485,448	Chad Gassert	Individual	20,000	€74.27
15 Aug 25	Sell€7,536,151	Esjay Llc	Company	100,000	€76.42
12 Aug 25	Sell€1,423,645	Thomas Haughey	Individual	19,341	€73.61
12 Aug 25	Sell€435,316	Ori Gutwerg	Individual	5,873	€74.12
12 Aug 25	Sell€4,192,691	Nikhil Lalwani	Individual	56,960	€73.61
12 Aug 25	Sell€365,260	Thomas Rowland	Individual	4,975	€73.42

Insider Trading Volume

Insider Buying: BSFA insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of BSFA?
Owner Type	Number of Shares	Ownership Percentage
State or Government	7,327	0.0276%
Private Companies	436,920	1.64%
Individual Insiders	1,348,785	5.07%
Institutions	24,796,058	93.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 69.91% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13%	BlackRock, Inc.	2,747,374	€193.9m	3.22%	no data
4.78%	MVP Capital Partners	1,014,381	€71.6m	0%	100.0%
3.88%	Vanguard Capital Management, LLC	823,064	€58.1m	0%	no data
3.87%	Soleus Capital Management, L.P.	820,243	€57.9m	68.7%	2.35%
3.64%	State Street Global Advisors, Inc.	771,587	€54.5m	6.1%	no data
3.34%	Tang Capital Management, LLC	707,500	€49.9m	47%	2.65%
3.15%	GoldenTree Asset Management LP	667,981	€47.1m	0%	2.92%
2.83%	Deep Track Capital, LP	600,000	€42.3m	25.6%	0.86%
2.79%	Millennium Management LLC	592,013	€41.8m	9.7%	0.03%
2.66%	Arrowstreet Capital, Limited Partnership	564,360	€39.8m	19.3%	0.02%
2.51%	Dimensional Fund Advisors LP	531,190	€37.5m	8.92%	0.01%
2.5%	UBS Asset Management AG	530,484	€37.4m	192%	no data
2.31%	Geode Capital Management, LLC	489,201	€34.5m	2.5%	no data
2.04%	Esjay Llc	431,920	€30.5m	0%	no data
1.77%	Vanguard Portfolio Management, LLC	375,965	€26.5m	0%	no data
1.7%	Global Alpha Capital Management Ltd.	361,240	€25.5m	-38.8%	0.76%
1.7%	Ranger Investment Management, L.P.	360,083	€25.4m	-0.63%	1.85%
1.65%	Nikhil Lalwani	349,889	€24.7m	20.5%	no data
1.54%	William Blair Investment Management, LLC	327,276	€23.1m	3.34%	0.03%
1.5%	Jones Hill Capital LP	318,591	€22.5m	0%	5.91%
1.45%	Invesco Capital Management LLC	308,268	€21.8m	77.4%	0.01%
1.39%	Kennedy Capital Management LLC	293,996	€20.7m	37.5%	0.44%
1.36%	Nomura Investment Management Business Trust	287,563	€20.3m	-3.91%	0.03%
1.32%	Parkman Healthcare Partners LLC	280,575	€19.8m	93.5%	2.28%
1.27%	Columbia Management Investment Advisers, LLC	270,262	€19.1m	0.13%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/12 19:59
End of Day Share Price	2026/06/12 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ANI Pharmaceuticals, Inc. is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Glen Santangelo	Barclays
Dewey Steadman	Canaccord Genuity
Timothy Chiang	Capital One Securities, Inc.